The US Food and Drug Administration has approved a new treatment for high blood pressure from Novartis which combines the renin inhibitor, aliskiren, with the calcium channel blocker, amlodipine, in a single pill. ---Subscribe to MedNous to access this article--- Company News Regulation & Policy
